Interaction of oxytocin with Ca2+: II. Proton magnetic resonance and molecular modeling studies of conformations of the hormone and its Ca2+ complex.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 9062068)

Published in Biopolymers on January 01, 1996

Authors

V S Ananthanarayanan1, M P Belciug, B S Zhorov

Author Affiliations

1: Department of Biochemistry, McMaster University, Hamilton, Ontario, Canada.

Articles by these authors

[Conformation of 1,3-bis(p-chlorobenzylidene amino)guanidine (chimcoccide) and its interaction with calcium ions]. Dokl Akad Nauk SSSR (1985) 2.57

[Guanidine derivatives as reversible inhibitors of cholinesterases of various origins: conformation and complex forming]. Zh Evol Biokhim Fiziol (2003) 1.58

[Relation between the rate of cholinesterase hydrolysis and the conformation of tertiary derivatives of acetylcholine]. Dokl Akad Nauk SSSR (1976) 1.17

Structure of the human 3alpha-hydroxysteroid dehydrogenase type 3 in complex with testosterone and NADP at 1.25-A resolution. J Biol Chem (2001) 1.01

[Distance between the ammonium groups of polymethylene bistrimethyl-ammonium compounds based on theoretical conformational analysis data]. Dokl Akad Nauk SSSR (1983) 1.01

[The conformational aspects of the interaction of the cholinesterases of Pacific Ocean squid and vertebrates with derivatives of polymethylene bis(trimethylammonium)]. Zh Evol Biokhim Fiziol (1995) 0.98

[A theoretical conformational analysis of several substrates of cholinesterase having a cyclic ammonium group structure]. Mol Biol (Mosk) (1976) 0.96

[Determination of productive conformations of acetylcholinesterase substrates using theoretical conformational analysis]. Bioorg Khim (1989) 0.95

Kinked-helices model of the nicotinic acetylcholine receptor ion channel and its complexes with blockers: simulation by the Monte Carlo minimization method. Biophys J (1998) 0.93

[Dependence of anti-acetylcholinesterase effectiveness of phosphoorganic inhibitors on the accessibility of the phosphorus atom]. Bioorg Khim (1992) 0.91

Interaction of substance P and its N- and C-terminal fragments with Ca2+: implications for hormone action. Biopolymers (1992) 0.87

[Boundaries of the butyrylcholinesterase anion site from data of a conformational analysis of substrates]. Zh Evol Biokhim Fiziol (1989) 0.85

Intersegment hydrogen bonds as possible structural determinants of the N/Q/R site in glutamate receptors. Biophys J (1999) 0.85

Architecture of the neuronal nicotinic acetylcholine receptor ion channel at the binding site of bis-ammonium blockers. J Membr Biol (1996) 0.83

1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 1): action in ion channels and GPCRs. Curr Med Chem (2011) 0.83

Interaction of oxytocin with Ca2+: I. CD and fluorescence spectral characterization and comparison with vasopressin. Biopolymers (1996) 0.81

1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 2): action in other targets and antitargets. Curr Med Chem (2012) 0.80

Interaction of calcium channel antagonists with calcium: spectroscopic and modeling studies on diltiazem and its Ca2+ complex. J Med Chem (1993) 0.80

[Topography of the active site of the noradrenaline neuronal membrane carrier based on the theoretical conformation analysis of inhibitors of neuronal catecholamine uptake]. Bioorg Khim (1983) 0.76

CD, 1H NMR and molecular modeling studies of the interaction of Ca2+ with substance P and Ala7-substance P in a non-polar solvent. J Pept Sci (2000) 0.76

[Predisposition of the optimal conformations of adrenergic compounds to the formation of polydentate complexes with metal ions]. Dokl Akad Nauk SSSR (1983) 0.75

Atomic model of the recognition site of the American cockroach pheromone receptor. J Chem Ecol (1996) 0.75

[Theoretical conformational analysis of methylamide of N-acetyl-L-lysine]. Mol Biol (Mosk) (1976) 0.75

[MOLECULAR EVOLUTION OF ION CHANNELS: AMINO ACID SEQUENCES AND 3D STRUCTURES]. Zh Evol Biokhim Fiziol (2016) 0.75

Two-H-bonded and one-H-bonded structure alternations in collagen. J Biomol Struct Dyn (1999) 0.75

[Structure of collagen with a new net of hydrogen bonds]. Bioorg Khim (1999) 0.75

[Conformations of alkylammonium and heterocyclic onium derivatives of acetylcholine and the boundary of the anionic center of butyrylcholinesterase]. Dokl Akad Nauk SSSR (1977) 0.75

[Simulation of DNA conformation possibilities by means of nonbonded interaction energy calculations of complementary dinucleoside phosphate complexes]. Mol Biol (Mosk) (1979) 0.75

Conformational studies on calcium binding by tBoc-Leu-Pro-Tyr-Ala-NHCH3, a tyrosine kinase substrate, in a nonpolar solvent. J Biomol Struct Dyn (1993) 0.75

[Characteristics of the electronic structure of catecholamines and their precursors]. Dokl Akad Nauk SSSR (1973) 0.75

Crystal structure of tert.-butyloxycarbonyl-L-prolyl-D-alanyl-D-alanyl-N-methylamide. Dimeric beta-sheet formation. Int J Pept Protein Res (1992) 0.75

[Productive conformations of ligands and topography of the alpha1-adrenoreceptor active site based on theoretical conformation analysis]. Bioorg Khim (1984) 0.75

Conformation of a synthetic hexapeptide substrate of collagen lysyl hydroxylase. Arch Biochem Biophys (1992) 0.75

[Sizes of the ionic channel of the nerve cell nicotinic cholinoreceptor at the site of its blocking with channel blockaders]. Dokl Akad Nauk SSSR (1989) 0.75

[Possible conformations of nucleic acid fragments containing the base pair guanine:uracil]. Biofizika (1982) 0.75

[Theoretical conformational analysis of methylamide N-acetyl-L-arginine]. Mol Biol (Mosk) (1976) 0.75

[Use of theoretical conformational analysis for solving the problem of the relationship between structure and action of cholinergic blockaders (difasil and amizil)]. Farmakol Toksikol (1981) 0.75

[Molecular physiology of adrenoreceptors]. Fiziol Zh SSSR Im I M Sechenova (1984) 0.75

[Conformational properties of the noradrenaline molecule]. Dokl Akad Nauk SSSR (1974) 0.75

Ligands of diltiazem binding site: an overview of some chemotypes. Mini Rev Med Chem (2009) 0.75